ORGANIX, INC.

Biotech · Acquired

Small-molecule therapeutic compounds that reduce Id-1 expression to inhibit tumor metastasis in aggressive breast cancer

Grants
$1.9M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
8
2 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Agriculture · Anaerobically Digested Manure Fiber For Environmental Cleanup And Remediation$82,000
Federal grantDepartment of Agriculture · Demonstration Of An Affordable And Scalable Anaerobic Digester And Fiber Processing System For Dairy Manure$83,736
Federal grantDepartment of Health and Human Services · Phase II · Targeting Breast Cancer Metastasis with Id1$178,146
Federal grantDepartment of Health and Human Services · Phase II · Targeting Breast Cancer Metastasis with Id1$809,827
Federal grantDepartment of Health and Human Services · Phase II · Targeting Breast Cancer Metastasis with Id1$743,502
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2757VAXFORM, LLC——
2758LINNAEUS BIOSCIENCE, INC.——
2759Lassen Therapeutics——
2760ORGANIX, INC.——
2761KOLIBER BIOSCIENCES INC.——
2762VIRTUS THERAPEUTICS CORPORATION——
2763SPECIFICA, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 8
  • Resorcinol-based Compounds And Uses Thereofgranted
  • Vmat Inhibitory Compoundsapplication
  • Vmat Inhibitory Compoundsgranted
  • Resorcinol-based Compounds And Uses Thereofapplication
  • Resorcinol-based Compounds And Uses Thereofapplication
  • Vmat Inhibitory Compoundsapplication
  • Stable Bisthiol Compounds For Radioimaging And Therapyapplication
  • Therapeutic Compoundsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.